Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing. We accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs). Our approach significantly reduces the timeline from lab research to clinical manufacturing, enabling faster delivery of critical therapies. At Axio BioPharma, we are committed to reducing the time it takes to get life-saving therapies to patients.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 504 S. Rosa Road,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.axiobiopharma.com/
- Keywords
- Biologics, Mammalian Expression, Contract Development, Contract Manufacturing, Antibodies, Protein Purification, CDMO, MKLP, Recombinant Proteins, Process Development, AI, High-Throughput Screening, Bioprocessing, Mammalian Cell Culture, Cell Line Development, Therapeutic Antibodies, Biomanufacturing, CMC Development, Biologics Scale-Up, Downstream Processing, Upstream Processing.
- HQ
- Madison, Wisconsin
Axio Biopharma Questions
Axio Biopharma's website is https://www.axiobiopharma.com/
Axio Biopharma's LinkedIn profile is https://www.linkedin.com/company/axio-biopharma
Axio Biopharma has
9 employees.
View email and phone details for 9
employees at Axio Biopharma.
Axio Biopharma's industry is
Biotechnology Research
Axio Biopharma's top competitors are
Genscript,
Astrazeneca,
Vertex Pharmaceuticals,
Aldevron,
Arrowhead Pharmaceuticals,
Axio Biosolutions,
Ambr Genomics,
Fujifilm Biotechnologies,
Arsenal Biosciences, Inc.,
Forward Biolabs.
Axio Biopharma's categories are Biotechnology Research
Axio Biopharma's founding year is 2024
